Company intelligence / Profile preview

Estuary Biotherapeutics, Inc.

Ownership: Private
Employees: ~4
Development stage: Other

Overview

Estuary Biotherapeutics is an early-stage biotechnology company founded in August 2022 and based in Menlo Park, California. The company is led by Wayne Sackett (Co-Founder & CEO), who has a strong track record in business development within the biotech sector. While specific details about its pipeline, therapeutic focus, and technology platform are not public as of May 2025, the company's leadership and advisory connections suggest a focus on innovative therapies for serious diseases—potentially rare genetic conditions—leveraging experience from prior roles at MyoKardia and other life science ventures.[1][2][3][4]

Therapeutic areas: Rare Diseases
Modalities: Not explicitly stated; likely genetic medicines or biologic therapeutics based on founder’s background and company positioning[3][5]
Industry: Biotech

Partnerships

No major partnerships disclosed as of May 2025.

Beyond the preview

Go deeper on Estuary Biotherapeutics, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Estuary Biotherapeutics, Inc..

Explore the full profile